ABOUT US

Our Company has expertise in the area of Heparins, Peptides and Biologicals.

We were funded by TIFAC, Government of India for the development of Low Molecular Weight Heparins, especially Parnaparin Sodium. We were the first company in India to develop and manufacture the API and formulation of Parnaparin (ACTIPARIN®).

We were the second company in India to develop and manufacture the API of Enoxaparin sodium and also introduced its formulation (INDENOX®).

We have collaborated with Centre for Biotechnology – Jawaharlal Nehru University under the Drugs and Pharmaceuticals Research Programme, Department of Science & Technology, Government of India for the development and production of recombinant Interferon β-1b used in the treatment of Multiple Sclerosis.

We have a comprehensive technology platform to develop and manufacture peptide therapeutics. Our company also has expertise in injectable and nasal spray formulations of peptides.